These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6534070)

  • 1. Compressibility and tablet properties of two polymorphs of metoprolol tartrate.
    Ragnarsson G; Sjögren J
    Acta Pharm Suec; 1984; 21(6):321-30. PubMed ID: 6534070
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
    Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Densitometric determination of metoprolol tartrate in pharmaceutical dosage forms.
    Vujic Z; Radulovic D; Agbaba D
    J Pharm Biomed Anal; 1997 Feb; 15(5):581-5. PubMed ID: 9127269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention.
    Narendra C; Srinath MS; Babu G
    AAPS PharmSciTech; 2006 Apr; 7(2):E34. PubMed ID: 16796352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrophotometric investigation of metoprolol-benzyl orange reaction and its application to the assay in pharmaceutical dosage forms.
    Vujic Z; Radulovic D; Zivanovic L
    Farmaco; 1995 Apr; 50(4):281-4. PubMed ID: 7669173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of Metolose structure on the free volume and the consequent metoprolol tartrate release of patches.
    Papp J; Marton S; Süvegh K; Zelkó R
    Int J Biol Macromol; 2009 Jan; 44(1):6-8. PubMed ID: 18940196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of Zwitterionic co-polymers as matrices for sustained metoprolol tartrate delivery.
    Kamenska E; Kostova B; Ivanov I; Rachev D; Georgiev G
    J Biomater Sci Polym Ed; 2009; 20(2):181-97. PubMed ID: 19154669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The consolidation and compressibility properties of some novel directly compressible filler-binders.
    Gönül N; Oğan-Hasçiçek C; Baykara T
    Acta Pol Pharm; 2000; 57(4):311-7. PubMed ID: 11126621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, synthesis, isolation and characterization of new impurity in metoprolol tartrate tablets.
    Reddy RB; More KR; Gupta L; Jha MS; Magar L
    J Pharm Biomed Anal; 2016 Jan; 117():104-8. PubMed ID: 26344385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods for the protection against counterfeit medications. Part 2. The assessment of interlot dispersion of the metoprolol succinate tablets fabricated by different manufacturers].
    Iakushev VA; Morozova MA; Elizarova TE; Fitilev SB; Pletneva TV
    Sud Med Ekspert; 2012; 55(5):46-8. PubMed ID: 23272565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of tablet geometry to tablet strength].
    Hüttenrauch R; Jacob J
    Pharmazie; 1981 Oct; 36(10):712-3. PubMed ID: 7312930
    [No Abstract]   [Full Text] [Related]  

  • 17. A felodipine-metoprolol extended-release tablet: its properties and clinical development.
    Dahlöf B; Andersson OK
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S43-7. PubMed ID: 7562899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous hydroxyapatite tablets as carriers for low-dosed drugs.
    Cosijns A; Vervaet C; Luyten J; Mullens S; Siepmann F; Van Hoorebeke L; Masschaele B; Cnudde V; Remon JP
    Eur J Pharm Biopharm; 2007 Sep; 67(2):498-506. PubMed ID: 17407810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isn't it easier to obtain metoprolol tartrate in the form of gastrointestinal diffusion system than the oral osmotic system form?
    Jedras Z
    Pharmazie; 1987 Jun; 42(6):417-8. PubMed ID: 3671464
    [No Abstract]   [Full Text] [Related]  

  • 20. [The pharmaceutical technology of tablet making. Physical processes taking place during tablet formation and the effect of pressure on properties of the tablets].
    Moldenhauer H; Kala H; Zessin G; Dittgen M
    Pharmazie; 1980; 35(11):714-26. PubMed ID: 7465618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.